Why the study?
Evidence-based treatments for pediatric persistent post-concussion symptoms are limited, and melatonin may improve complaints like sleep disturbance and fatigue.
Does melatonin improve post-concussion symptoms in children with persistent post-concussion symptoms?
Does melatonin improve post-concussion symptoms in children with persistent post-concussion symptoms?
Melatonin treatment in pediatric concussion did not improve overall recovery but was associated with structural and functional brain changes that correlated with improved sleep parameters.
Melatonin failed to improve overall PPCS recovery; leaves open whether DMN-linked sleep changes merit targeted trials in select patients.
Evidence-based treatments for children with persistent post-concussion symptoms (PPCS) are few and limited. Common PPCS complaints such as sleep disturbance and fatigue could be ameliorated via the supplementation of melatonin, which has significant neuroprotective and anti-inflammatory properties. This study aims to identify neural correlates of melatonin treatment with changes in sleep disturbances and clinical recovery in a pediatric cohort with PPCS. We examined structural and functional neuroimaging (MRI) in 62 children with PPCS in a randomized, double-blind, placebo-controlled trial of 3mg or 10mg of melatonin ( NCT01874847 ). The primary outcome was the total youth self-report Post-Concussion Symptom Inventory (PCSI) score after 28 days of treatment. Secondary outcomes included the change in the sleep domain PCSI score and sleep-wake behavior (assessed using wrist-worn actigraphy). Whole-brain analyses of (i) functional connectivity (FC) of resting-state fMRI, and (ii) structural grey matter (GM) volumes via voxel-based morphometry were assessed immediately before and after melatonin treatment and compared to placebo in order to identify neural effects of melatonin treatment. Increased FC of posterior default mode network (DMN) regions with visual, somatosensory and dorsal networks was detected in the melatonin groups over time. FC increases also corresponded with reduced wake periods ( r= −0.27, p= 0.01). Children who did not recover ( n =39) demonstrated significant FC increases within anterior DMN and limbic regions compared to those that did recover (i.e. PCSI scores returned to pre-injury level n =23) over time, ( p= 0.026). Increases in GM volume within the posterior cingulate cortex were found to correlate with reduced wakefulness after sleep onset ( r= −0.32, p= 0.001) and sleep symptom improvement ( r= 0.29, p= 0.02). Although the melatonin treatment trial was negative and did not result in PPCS recovery (with or without sleep problems), the relationship between melatonin and improvement in sleep parameters were linked to changes in function-structure within and between brain regions interacting with the DMN.
No takes yet. Share an insight, caveat, or question.
Iyer et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: